Literature DB >> 19419571

High-resolution analysis of copy number alterations and associated expression changes in ovarian tumors.

Peter M Haverty1, Lawrence S Hon, Joshua S Kaminker, John Chant, Zemin Zhang.   

Abstract

BACKGROUND: DNA copy number alterations are frequently observed in ovarian cancer, but it remains a challenge to identify the most relevant alterations and the specific causal genes in those regions.
METHODS: We obtained high-resolution 500K SNP array data for 52 ovarian tumors and identified the most statistically significant minimal genomic regions with the most prevalent and highest-level copy number alterations (recurrent CNAs). Within a region of recurrent CNA, comparison of expression levels in tumors with a given CNA to tumors lacking that CNA and to whole normal ovary samples was used to select genes with CNA-specific expression patterns. A public expression array data set of laser capture micro-dissected (LCM) non-malignant fallopian tube epithelia and LCM ovarian serous adenocarcinoma was used to evaluate the effect of cell-type mixture biases.
RESULTS: Fourteen recurrent deletions were detected on chromosomes 4, 6, 9, 12, 13, 15, 16, 17, 18, 22 and most prevalently on X and 8. Copy number and expression data suggest several apoptosis mediators as candidate drivers of the 8p deletions. Sixteen recurrent gains were identified on chromosomes 1, 2, 3, 5, 8, 10, 12, 15, 17, 19, and 20, with the most prevalent gains localized to 8q and 3q. Within the 8q amplicon, PVT1, but not MYC, was strongly over-expressed relative to tumors lacking this CNA and showed over-expression relative to normal ovary. Likewise, the cell polarity regulators PRKCI and ECT2 were identified as putative drivers of two distinct amplicons on 3q. Co-occurrence analyses suggested potential synergistic or antagonistic relationships between recurrent CNAs. Genes within regions of recurrent CNA showed an enrichment of Cancer Census genes, particularly when filtered for CNA-specific expression.
CONCLUSION: These analyses provide detailed views of ovarian cancer genomic changes and highlight the benefits of using multiple reference sample types for the evaluation of CNA-specific expression changes.

Entities:  

Year:  2009        PMID: 19419571      PMCID: PMC2694826          DOI: 10.1186/1755-8794-2-21

Source DB:  PubMed          Journal:  BMC Med Genomics        ISSN: 1755-8794            Impact factor:   3.063


  46 in total

1.  Robust estimators for expression analysis.

Authors:  Earl Hubbell; Wei-Min Liu; Rui Mei
Journal:  Bioinformatics       Date:  2002-12       Impact factor: 6.937

2.  Cancer: drivers and passengers.

Authors:  Daniel A Haber; Jeff Settleman
Journal:  Nature       Date:  2007-03-08       Impact factor: 49.962

3.  The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers.

Authors:  Kwai Wa Cheng; John P Lahad; Wen-Lin Kuo; Anna Lapuk; Kyosuke Yamada; Nelly Auersperg; Jinsong Liu; Karen Smith-McCune; Karen H Lu; David Fishman; Joe W Gray; Gordon B Mills
Journal:  Nat Med       Date:  2004-10-24       Impact factor: 53.440

4.  Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma.

Authors:  Janice M Nigro; Anjan Misra; Li Zhang; Ivan Smirnov; Howard Colman; Chandi Griffin; Natalie Ozburn; Mingang Chen; Edward Pan; Dimpy Koul; W K Alfred Yung; Burt G Feuerstein; Kenneth D Aldape
Journal:  Cancer Res       Date:  2005-03-01       Impact factor: 12.701

5.  High-resolution characterization of the pancreatic adenocarcinoma genome.

Authors:  Andrew J Aguirre; Cameron Brennan; Gerald Bailey; Raktim Sinha; Bin Feng; Christopher Leo; Yunyu Zhang; Jean Zhang; Joseph D Gans; Nabeel Bardeesy; Craig Cauwels; Carlos Cordon-Cardo; Mark S Redston; Ronald A DePinho; Lynda Chin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-15       Impact factor: 11.205

6.  Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target.

Authors:  Marlena S Fejzo; Judy Dering; Chuck Ginther; Lee Anderson; Lilian Ramos; Christine Walsh; Beth Karlan; Dennis J Slamon
Journal:  Genes Chromosomes Cancer       Date:  2008-10       Impact factor: 5.006

7.  The identification of microRNAs in a genomically unstable region of human chromosome 8q24.

Authors:  Konrad Huppi; Natalia Volfovsky; Timothy Runfola; Tamara L Jones; Mark Mackiewicz; Scott E Martin; J Frederic Mushinski; Robert Stephens; Natasha J Caplen
Journal:  Mol Cancer Res       Date:  2008-02       Impact factor: 5.852

8.  High-resolution single nucleotide polymorphism array analysis of epithelial ovarian cancer reveals numerous microdeletions and amplifications.

Authors:  Kylie L Gorringe; Sharoni Jacobs; Ella R Thompson; Anita Sridhar; Wen Qiu; David Y H Choong; Ian G Campbell
Journal:  Clin Cancer Res       Date:  2007-08-15       Impact factor: 12.531

9.  Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma.

Authors:  C Collins; J M Rommens; D Kowbel; T Godfrey; M Tanner; S I Hwang; D Polikoff; G Nonet; J Cochran; K Myambo; K E Jay; J Froula; T Cloutier; W L Kuo; P Yaswen; S Dairkee; J Giovanola; G B Hutchinson; J Isola; O P Kallioniemi; M Palazzolo; C Martin; C Ericsson; D Pinkel; D Albertson; W B Li; J W Gray
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

10.  PIK3CA is implicated as an oncogene in ovarian cancer.

Authors:  L Shayesteh; Y Lu; W L Kuo; R Baldocchi; T Godfrey; C Collins; D Pinkel; B Powell; G B Mills; J W Gray
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

View more
  46 in total

1.  A potent and selective inhibitor of KIAA1363/AADACL1 that impairs prostate cancer pathogenesis.

Authors:  Jae Won Chang; Daniel K Nomura; Benjamin F Cravatt
Journal:  Chem Biol       Date:  2011-04-22

2.  p53-Dependent induction of PVT1 and miR-1204.

Authors:  Anthony M Barsotti; Rachel Beckerman; Oleg Laptenko; Konrad Huppi; Natasha J Caplen; Carol Prives
Journal:  J Biol Chem       Date:  2011-11-22       Impact factor: 5.157

3.  Protein kinase Cι promotes UBF1-ECT2 binding on ribosomal DNA to drive rRNA synthesis and transformed growth of non-small-cell lung cancer cells.

Authors:  Verline Justilien; Kayla C Lewis; Kayleah M Meneses; Lee Jamieson; Nicole R Murray; Alan P Fields
Journal:  J Biol Chem       Date:  2020-04-29       Impact factor: 5.157

Review 4.  The metabolic serine hydrolases and their functions in mammalian physiology and disease.

Authors:  Jonathan Z Long; Benjamin F Cravatt
Journal:  Chem Rev       Date:  2011-06-23       Impact factor: 60.622

5.  Genomic imbalances in esophageal carcinoma cell lines involve Wnt pathway genes.

Authors:  Jacqueline Brown; Hannelie Bothma; Robin Veale; Pascale Willem
Journal:  World J Gastroenterol       Date:  2011-06-28       Impact factor: 5.742

6.  Human ortholog of Drosophila Melted impedes SMAD2 release from TGF-β receptor I to inhibit TGF-β signaling.

Authors:  Premalatha Shathasivam; Alexandra Kollara; Maurice J Ringuette; Carl Virtanen; Jeffrey L Wrana; Theodore J Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-26       Impact factor: 11.205

7.  Identification of candidate growth promoting genes in ovarian cancer through integrated copy number and expression analysis.

Authors:  Manasa Ramakrishna; Louise H Williams; Samantha E Boyle; Jennifer L Bearfoot; Anita Sridhar; Terence P Speed; Kylie L Gorringe; Ian G Campbell
Journal:  PLoS One       Date:  2010-04-08       Impact factor: 3.240

8.  Complex sense-antisense architecture of TNFAIP1/POLDIP2 on 17q11.2 represents a novel transcriptional structural-functional gene module involved in breast cancer progression.

Authors:  Oleg V Grinchuk; Efthimios Motakis; Vladimir A Kuznetsov
Journal:  BMC Genomics       Date:  2010-02-10       Impact factor: 3.969

9.  Copy number analysis identifies novel interactions between genomic loci in ovarian cancer.

Authors:  Kylie L Gorringe; Joshy George; Michael S Anglesio; Manasa Ramakrishna; Dariush Etemadmoghadam; Prue Cowin; Anita Sridhar; Louise H Williams; Samantha E Boyle; Nozomu Yanaihara; Aikou Okamoto; Mitsuyoshi Urashima; Gordon K Smyth; Ian G Campbell; David D L Bowtell
Journal:  PLoS One       Date:  2010-09-10       Impact factor: 3.240

10.  Identification of networks of co-occurring, tumor-related DNA copy number changes using a genome-wide scoring approach.

Authors:  Christiaan Klijn; Jan Bot; David J Adams; Marcel Reinders; Lodewyk Wessels; Jos Jonkers
Journal:  PLoS Comput Biol       Date:  2010-01-01       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.